Fundraising FoxNeuroReserve
Las Vegas, US · Founded 2017 · Delaware corporation · 1 known investors
Find your way into NeuroReserve
Sign up to see every warm intro you have to NeuroReserve
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NeuroReserve team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeuroReserve Inc. is a US consumer nutrition company that develops dietary supplements and food products aimed at supporting long-term brain and cognitive health. Its main product, RELEVATE, is a 17-nutrient softgel-and-capsule regimen formulated around nutrients found in Mediterranean and MIND dietary patterns, alongside offerings such as extra virgin olive oil, creatine and an omega-3 product, guided by a medical and scientific advisory team.
Founders & leadership
NeuroReserve was founded in 2017 by Edward Park, Ph.D., M.S..
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.7M disclosed across 5 rounds · 2019–2025
▶$691.2KraisedApr 2025 · 5 investors · Other Health CareRule 506(b)
- Edward S. ParkExecutive Officer, Director
- Robert NewellDirector
- Offering amount
- $691.2K
- Amount sold
- $691.2K
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedDec 2023 · 34 investors · Other Health CareRule 506(b)
- Robert NewellDirector
- Edward S. ParkExecutive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $1.4M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$295KraisedSep 2021 · 14 investors · Other Health CareRule 506(b)
- Edward S. ParkExecutive Officer, Director
- Offering amount
- $350K
- Amount sold
- $295K
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$240KraisedAug 2020 · 8 investors · Other Health CareRule 506(b)
- Edward S. ParkExecutive Officer, Director
- Offering amount
- $475K
- Amount sold
- $240K
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$50KraisedMay 2019 · 4 investors · Other Health CareRule 506(b)
- Edward S. ParkExecutive Officer, Director
- Offering amount
- $125K
- Amount sold
- $50K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does NeuroReserve do?
- NeuroReserve Inc. is a US consumer nutrition company that develops dietary supplements and food products aimed at supporting long-term brain and cognitive health. Its main product, RELEVATE, is a 17-nutrient softgel-and-capsule regimen formulated around nutrients found in Mediterranean and MIND dietary patterns, alongside offerings such as extra virgin olive oil, creatine and an omega-3 product, guided by a medical and scientific advisory team.
- Who founded NeuroReserve?
- NeuroReserve was founded by Edward Park, Ph.D., M.S. in 2017.
- Who are NeuroReserve's investors?
- NeuroReserve's investors include Reno Seed Fund.
- How much funding has NeuroReserve raised?
- NeuroReserve has disclosed $2.7M raised across 5 rounds.
- Where is NeuroReserve headquartered?
- NeuroReserve is headquartered in Las Vegas, US.